FDA

Stories 41 - 60 | << Prev   Next >>

This Is Why You Shouldn't Bring a Gun Into an MRI

Patient, 57, ended up shot in the butt after sneaking a firearm into the machine

(Newser) - It might seem obvious to most that one probably shouldn't bring a firearm into a large machine with a powerful magnetic field, but one woman learned that lesson the hard way. The Messenger first reported on the "adverse event" cited by the Food and Drug Administration , in which...

Salmonella Infections Linked to Cantaloupe Kill 3

Authorities warn people not to eat pre-cut cantaloupe if they don't know the source

(Newser) - Consumers shouldn't eat pre-cut cantaloupe if they don't know the source, US health officials said Thursday, as the number of illnesses and recalls tied to a deadly salmonella outbreak grows. At least 117 people in 34 US states have been sickened by contaminated cantaloupe, including 61 who were...

FDA Proposes Banning Controversial Pop Ingredient

California has already banned brominated vegetable oil

(Newser) - The Food and Drug Administration might follow California's lead with a ban on a controversial ingredient found in some citrus-flavored soft drinks. CBS News reports that the agency has proposed banning brominated vegetable oil, which has been used in drinks for around a century. The ingredient, which includes bromine,...

FDA: These Eyedrops Could Blind You
FDA Warns:
These Eyedrops
Could Blind You
IN CASE YOU MISSED IT
Nov 4, 2023 4:10 PM CDT

FDA Warns: These Eyedrops Could Blind You

Affected eyedrops should no longer be used, agency warns

(Newser) - US health regulators are warning consumers not to use more than two dozen varieties of over-the-counter eyedrops because of the risk of infections that could lead to blindness, the AP reports. The Food and Drug Administration advisory applies to lubricating drops sold by six companies, including CVS Health, Target, Rite...

It Feels 'Like Being Stabbed All Over.' A New Cure Is Closer

Panel clears CRISPR gene-editing product for sickle cell disease patients; FDA to weigh in

(Newser) - Sickle cell disease is a painful, debilitating, and possibly deadly inherited disorder that currently can only be remedied with a bone marrow transplant. Now, Boston's Vertex Pharmaceuticals hopes exa-cel, its treatment developed with CRISPR Therapeutics, will soon be approved by the FDA following a thumbs-up from a panel of...

If You Had This Fruit Puree Pouch, Get a Blood Test

FDA says some WanaBana products have 'extremely high concentrations of lead'

(Newser) - WanaBana fruit puree pouches might sound like a healthy option for parents to give their kids, but the FDA is warning that anyone who consumed one should get their blood tested for what appears to be "extremely high concentrations of lead." As the New York Times reports, the...

'Toddler Milks' Are Unregulated and Unnecessary

American Academy of Pediatrics weighs in

(Newser) - Powdered drink mixes that are widely promoted as "toddler milks" for older babies and children up to age 3 are unregulated, unnecessary, and "nutritionally incomplete," the American Academy of Pediatrics warns. The drinks, which are touted to parents on TikTok, in television ads, and on other sites,...

CVS Yanks Completely Ineffective Cold Meds

Move comes after FDA found oral phenylephrine to be a useless decongestant

(Newser) - CVS Health is pulling various cough and cold medicines from its shelves after an FDA advisory panel determined the active ingredient doesn't work. Phenylephrine, approved in the 1930s, has long been found in over-the-counter syrups and pills meant to resolve sinus congestion. However, an FDA analysis found the ingredient,...

Japan's Dementia Treatment 'Has Now Entered a New Era'

Country with rapidly aging population OKs its first Alzheimer's drug

(Newser) - Japan's Health Ministry has approved Leqembi, a drug for Alzheimer's disease that was jointly developed by Japanese and US pharmaceutical companies. As the AP reports, it's the first drug for treatment of the disease in a country with a rapidly aging population. Developed by Japanese drugmaker Eisai...

In Surprise Move, FDA Rejects Needle-Free EpiPen Rival

It wants ARS Pharmaceuticals to conduct additional research on its Neffy nasal spray

(Newser) - In a surprise move, the FDA declined to grant approval to a nasal spray that would be the first needle-free alternative to epinephrine autoinjectors—more commonly referred to by the brand name EpiPen. In May, the FDA's advisory committee voted to recommend approval of ARS Pharmaceuticals' Neffy. But in...

Latest COVID Vaccinations Could Begin This Week
You Can Now Get Your
Updated COVID Vaccine
UPDATED
Sep 13, 2023 12:41 AM CDT

You Can Now Get Your Updated COVID Vaccine

Shots beginning this week, as soon as Wednesday in some locations

(Newser) - Most Americans should get an updated COVID-19 vaccine, health officials said Tuesday. Advisers to the Centers for Disease Control and Prevention endorsed the new shots for everyone 6 months and older and the agency's director quickly signed off Tuesday on the panel's recommendation. That means doses should be...

Popular Nasal Decongestant Doesn't Work, Says FDA Panel

Products with phenylephrine, or PE, won't help your stuffy nose, say advisers

(Newser) - The leading decongestant used by millions of Americans looking for relief from a stuffy nose is likely no better than a dummy pill, according to government experts who reviewed the latest research on the long-questioned drug ingredient. Advisers to the Food and Drug Administration voted unanimously on Tuesday against the...

Some Think It's High Time to Improve US Sunscreen

AOC is among those trying to nudge Congress and the FDA

(Newser) - Nearly a decade ago, Congress got interested in improving the quality of sunscreen in the US, which is generally considered sub-par when compared to products offered elsewhere in the world. The result in 2023: Not much has happened. Now the interest is percolating again, as evidenced in an Instagram video...

FDA Has Big News on Postpartum Depression Front

Sage Therapeutics introduces fast-acting Zurzuvae, the first pill for condition afflicting new moms

(Newser) - Hundreds of thousands of women suffer from postpartum depression annually, and while the serious condition that emerges after childbirth often resolves within weeks, for other women, it can stretch for months, even years, and cause feelings that may even prove dangerous. Now, the Food and Drug Administration has announced a...

Drug to Protect Babies From RSV Gets Green Light

FDA approves drug to ward off respiratory virus that kills hundreds of kids every year

(Newser) - US officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year. RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and...

First No-Prescription Birth Control Pill Is Approved

Opill will likely be available in stores early next year following FDA move

(Newser) - It's a US milestone in regard to birth control: The FDA on Thursday approved the first over-the-counter pill to prevent pregnancies, reports CNN . The medication called Opill, made by Perrigo Company, is expected to be available in stores in early 2024. No word yet on cost, though Perrigo says...

Influencer-Backed Energy Drink Has People Worried

Lawmakers want FDA to investigate PRIME

(Newser) - An influencer-backed energy drink that has earned viral popularity among children is facing scrutiny from lawmakers and health experts over its potentially dangerous levels of caffeine, the AP reports. On Sunday, Sen. Charles Schumer called on the Food and Drug Administration to investigate PRIME, a beverage brand founded by the...

FDA Makes a Big Move on Alzheimer's Treatment

Drug Leqembi, shown to slow progression, receives full approval

(Newser) - In a move with big implications for Alzheimer's treatment, the FDA on Thursday gave full approval to the first drug shown to slow the disease's progression, though modestly, reports the Washington Post . The drug, called Leqembi and marketed by Eisai and Biogen, received conditional approval back in January....

Alzheimer's Drug Receives Experts' Support for Approval

Leqembi, which already has conditional OK, costs about as much as Aduhelm

(Newser) - Health advisers on Friday unanimously backed the full approval of a closely watched Alzheimer's drug, a key step toward opening insurance coverage to US seniors with early stages of the brain-robbing disease. The drug, Leqembi, received conditional approval from the Food and Drug Administration in January based on early...

Eye Drops Recall: Deaths, Blindness, Now an FDA Inspection
Eyedrops Recall:
4th Death Linked to Outbreak
updated
May 22, 2023 11:05 AM CDT

Eyedrops Recall: 4th Death Linked to Outbreak

CDC counts more than 80 people affected in 18 states by EzriCare artificial tears

(Newser) - A fourth death has been linked to an outbreak of drug-resistant bacteria blamed on eyedrops, reports USA Today . The CDC now counts 81 patients in 18 states affected by the outbreak, which prompted the recall of EzriCare artificial tears, made by Global Pharma Healthcare. The CDC also warns people to...

Stories 41 - 60 | << Prev   Next >>
Most Read on Newser